Tenax Therapeutics (TENX) EBT Margin (2010 - 2015)

Tenax Therapeutics has disclosed EBT Margin across 5 years of filings, most recently posting 9877.81% for Q2 2015.

• In Q2 2015, EBT Margin changed N/A year-over-year to 9877.81%; the TTM figure through Jun 2016 stood at 29552.48% (down 2844781.0% YoY), while the FY2015 annual figure was 33595.91%, changed N/A from the prior year.
• EBT Margin came in at 9877.81% for Q2 2015 at Tenax Therapeutics, down from 1025.76% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 10522.58% in Q1 2011 to a low of 11513.99% in Q3 2011.
• Average EBT Margin over 4 years is 1715.48%, with a median of 1323.56% recorded in 2012.
• The largest YoY upside for EBT Margin was 1019043 bps in 2012 against a maximum downside of 1538948 bps in 2012.
• Over 4 years, EBT Margin stood at 3074.85% in 2011, then surged by 90 bps to 301.12% in 2012, then tumbled by 241 bps to 1025.76% in 2013, then sank by 863 bps to 9877.81% in 2015.
• Per Business Quant data, the three most recent EBT Margin figures were 9877.81% in Q2 2015, 1025.76% in Q2 2013, and 1085.17% in Q1 2013.